Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 3096 (LINC03096) is a human long intergenic non-coding RNA, defined as a class of RNA molecules longer than 200 nucleotides that do not overlap annotated coding regions and are transcribed from intergenic regions[3][5]. LINC03096, like other lincRNAs, is presumed to have a regulatory role in gene expression, chromatin architecture, and possibly in modulating transcription of neighboring genes, though its precise biological functions, disease relevance, and mechanisms remain uncharacterized[3]. There is no evidence that LINC03096 is a protein, receptor, enzyme, transporter, or other empirically validated drug target, and it currently lacks utility as a biomarker or disease indicator.
None for drugs, as it is not a validated pharmacological target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 3096 (LINC03096).